Xinyuan shares: it is proposed to launch the restricted stock incentive plan in 2022

Synthetic Biology: Who Will Emerge as the Winner?

The 21st century is the century of biology. Synthetic biology is believed to be a ‘World Changing’ industry. But the potential risks like cost control and commercialization pathways are fatefully tied to the ups and downs of countless investment decisions and the destiny of the many new start-ups getting involved. We look forward to seeing an emerging ‘giant’ on the horizon of this exciting industry.

iSoftStone Subsidiary Signs USD 190 Million MECHREVO Laptop Contract

iSoftStone（软通动力）said on October 27 that its wholly owned subsidiary Aistone Global Limited（智通国际）had signed a USD 190.35 million contract to supply 309,000 MECHREVO（机械革命）laptops and warranty services through local repair centres.

Lens Technology Reports AI Server Component Orders as Dongguan Capacity Enters Ramp-Up

Lens Technology（蓝思科技）said in an October 26 investor-relations disclosure that it had completed an expansion of AI server-related capacity at its Songshan Lake campus in Dongguan. The company said liquid-cooling modules, high-end precision cabinets and high-speed optical interconnect components had passed validation by leading North American computing companies and secured volume orders, with production entering the ramp-up stage.

DSBJ Sets Hong Kong Offer Price at HK$86.80 Ahead of Planned October 28 Listing

Suzhou Dongshan Precision Manufacturing Co., Ltd.（苏州东山精密制造股份有限公司）, known as DSBJ, disclosed a final Hong Kong offer price of HK$86.80 per share ahead of its scheduled October 28 main-board debut. The offering would give the Chinese electronics manufacturer an additional offshore financing channel as it expands its printed circuit board and optical communications businesses.

Bloomage: Injecting Biotechnology into Beauty Care

Listed on the Chinese Star Market in November 2019, Bloomage was trading at CNY 138.01 as of June 24, 2020, over 38% higher than the IPO price of CNY 100.